| Microcrystalline cellulose, a direct compression binder in a quality by design environment—A review G Thoorens, F Krier, B Leclercq, B Carlin, B Evrard International journal of pharmaceutics 473 (1-2), 64-72, 2014 | 693 | 2014 |
| Systematic characterization of oil-in-water emulsions for formulation design I Roland, G Piel, L Delattre, B Evrard International journal of pharmaceutics 263 (1-2), 85-94, 2003 | 346 | 2003 |
| Nanocarriers for the treatment of glioblastoma multiforme: current state-of-the-art R Karim, C Palazzo, B Evrard, G Piel Journal of controlled release 227, 23-37, 2016 | 259 | 2016 |
| Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications S Jaspart, G Piel, L Delattre, B Evrard Expert opinion on drug delivery 2 (1), 75-87, 2005 | 215 | 2005 |
| Design space approach in the optimization of the spray-drying process P Lebrun, F Krier, J Mantanus, H Grohganz, M Yang, E Rozet, ... European Journal of Pharmaceutics and Biopharmaceutics 80 (1), 226-234, 2012 | 206 | 2012 |
| A review of pharmaceutical extrusion: Critical process parameters and scaling-up J Thiry, F Krier, B Evrard International journal of pharmaceutics 479 (1), 227-240, 2015 | 182 | 2015 |
| Solid lipid microparticles as a sustained release system for pulmonary drug delivery S Jaspart, P Bertholet, G Piel, JM Dogné, L Delattre, B Evrard European journal of pharmaceutics and biopharmaceutics 65 (1), 47-56, 2007 | 182 | 2007 |
| Liposome surface charge influence on skin penetration behaviour A Gillet, P Compère, F Lecomte, P Hubert, E Ducat, B Evrard, G Piel International journal of pharmaceutics 411 (1-2), 223-231, 2011 | 160 | 2011 |
| Application of supercritical carbon dioxide for the preparation of a piroxicam-β-cyclodextrin inclusion compound T Van Hees, G Piel, B Evrard, X Otte, L Thunus, L Delattre Pharmaceutical research 16, 1864-1870, 1999 | 158 | 1999 |
| Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives ML Volvert, S Seyen, M Piette, B Evrard, M Gangolf, JC Plumier, ... BMC pharmacology 8, 1-11, 2008 | 157 | 2008 |
| Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors. DD Cataldo, MM Gueders, N Rocks, NE Sounni, B Evrard, P Bartsch, ... Cellular and molecular biology (Noisy-le-Grand, France) 49 (6), 875-884, 2003 | 156 | 2003 |
| Skin penetration behaviour of liposomes as a function of their composition A Gillet, F Lecomte, P Hubert, E Ducat, B Evrard, G Piel European Journal of Pharmaceutics and Biopharmaceutics 79 (1), 43-53, 2011 | 139 | 2011 |
| Supercritical fluid methods: An alternative to conventional methods to prepare liposomes B William, P Noemie, E Brigitte, P Geraldine Chemical Engineering Journal 383, 123106, 2020 | 125 | 2020 |
| Challenges of fused deposition modeling 3D printing in pharmaceutical applications: where are we now? C Parulski, O Jennotte, A Lechanteur, B Evrard Advanced drug delivery reviews 175, 113810, 2021 | 124 | 2021 |
| Moisture content determination of pharmaceutical pellets by near infrared spectroscopy: method development and validation J Mantanus, E Ziemons, P Lebrun, E Rozet, R Klinkenberg, B Streel, ... Analytica chimica acta 642 (1-2), 186-192, 2009 | 123 | 2009 |
| Betamethasone-in-cyclodextrin-in-liposome: the effect of cyclodextrins on encapsulation efficiency and release kinetics G Piel, M Piette, V Barillaro, D Castagne, B Evrard, L Delattre International journal of pharmaceutics 312 (1-2), 75-82, 2006 | 118 | 2006 |
| Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-β-cyclodextrin B Evrard, P Chiap, P DeTullio, F Ghalmi, G Piel, T Van Hees, J Crommen, ... Journal of Controlled Release 85 (1-3), 45-50, 2002 | 115 | 2002 |
| Influence of composition and spray-drying process parameters on carrier-free DPI properties and behaviors in the lung: A review A Lechanteur, B Evrard Pharmaceutics 12 (1), 55, 2020 | 109 | 2020 |
| Cationic liposomes carrying siRNA: impact of lipid composition on physicochemical properties, cytotoxicity and endosomal escape A Lechanteur, V Sanna, A Duchemin, B Evrard, D Mottet, G Piel Nanomaterials 8 (5), 270, 2018 | 109 | 2018 |
| Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration V Sanna, N Kirschvink, P Gustin, E Gavini, I Roland, L Delattre, B Evrard AAPS pharmscitech 5, 17-23, 2004 | 109 | 2004 |
